Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03587311
Brief Title: Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

First Submitted : July 13, 2018
First Submitted that Met QC Criteria : July 13, 2018
First Posted : July 16, 2018

Last Update Submitted that Met QC Criteria : July 2, 2021
Last Update Posted : July 6, 2021